Trialect

Verified

NOIP: Holistic and Evidence-Informed Wellness for STI Prevention

Centers for Disease Control and Prevention

Note: This is a Forecasted Opportunity.

STIs represent a serious public health and economic burden in the United States (U.S.), with approximately 2.2 million new infections occurring each year. As the nation's lead public health agency, the Centers for Disease Control and Prevention (CDC) has a unique responsibility to provide national leadership in STI prevention and control. To meet this challenge, CDC supports a comprehensive and integrated approach to STI prevention that goes beyond simply addressing the absence of disease. It empowers individuals to make healthy choices and build healthy relationships, as an approach to reducing STIs in the U.S. This whole-person approach focuses not just on physical health, but also considers the emotional, mental, and social well-being of the individual.

A key component of this approach is supporting a national coalition of sexual health and wellness expertise that allows for the strategic use of limited resources for STI prevention. The coalition brings together a range of organizations, clinical experts, and individuals committed to comprehensive and holistic sexual health and wellness frameworks for STI prevention. The goal is for them to work together to share clear, accurate information, promote quality sexual health care, and empower individuals and communities to make choices that improve health and reduce STI risk – with a particular focus on priority groups most affected by STIs.

This funding strengthens STI prevention efforts by supporting coalition management and the development, promotion, and dissemination of high-quality, evidence-based sexual health-related materials, resources, and tools to their partners, health care providers, and the public. Together, these efforts complement and supplement traditional STI prevention strategies, accelerating progress toward increasing timely diagnoses and treatment and reducing the STI morbidity in the U.S.

Estimated Post Date:

Mar 29, 2027

Estimated Application Due Date:

May 31, 2027

Specialties

Curriculum Development

Medical - Clinical Science

Medical

Medical - Translational

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: Centers for Disease Control and Prevention

Sponsor Type: Government/Federal

Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity